276 related articles for article (PubMed ID: 15221935)
1. Hyperphosphorylation of pRb: a mechanism for RB tumour suppressor pathway inactivation in bladder cancer.
Chatterjee SJ; George B; Goebell PJ; Alavi-Tafreshi M; Shi SR; Fung YK; Jones PA; Cordon-Cardo C; Datar RH; Cote RJ
J Pathol; 2004 Jul; 203(3):762-70. PubMed ID: 15221935
[TBL] [Abstract][Full Text] [Related]
2. Deregulation of cyclin E and D1 in breast cancer is associated with inactivation of the retinoblastoma protein.
Nielsen NH; Emdin SO; Cajander J; Landberg G
Oncogene; 1997 Jan; 14(3):295-304. PubMed ID: 9018115
[TBL] [Abstract][Full Text] [Related]
3. Different combinations of genetic/epigenetic alterations inactivate the p53 and pRb pathways in invasive human bladder cancers.
Sarkar S; Jülicher KP; Burger MS; Della Valle V; Larsen CJ; Yeager TR; Grossman TB; Nickells RW; Protzel C; Jarrard DF; Reznikoff CA
Cancer Res; 2000 Jul; 60(14):3862-71. PubMed ID: 10919661
[TBL] [Abstract][Full Text] [Related]
4. Role of p16/MTS1, cyclin D1 and RB in primary oral cancer and oral cancer cell lines.
Sartor M; Steingrimsdottir H; Elamin F; Gäken J; Warnakulasuriya S; Partridge M; Thakker N; Johnson NW; Tavassoli M
Br J Cancer; 1999 Apr; 80(1-2):79-86. PubMed ID: 10389982
[TBL] [Abstract][Full Text] [Related]
5. The role of pRB, p16 and cyclin D1 in colonic carcinogenesis.
Ayhan S; Isisag A; Saruc M; Nese N; Demir MA; Kucukmetin NT
Hepatogastroenterology; 2010; 57(98):251-6. PubMed ID: 20583423
[TBL] [Abstract][Full Text] [Related]
6. Cyclin D1 amplification is independent of p16 inactivation in head and neck squamous cell carcinoma.
Okami K; Reed AL; Cairns P; Koch WM; Westra WH; Wehage S; Jen J; Sidransky D
Oncogene; 1999 Jun; 18(23):3541-5. PubMed ID: 10376532
[TBL] [Abstract][Full Text] [Related]
7. Alterations of expression of Rb, p16(INK4A) and cyclin D1 in non-small cell lung carcinoma and their clinical significance.
Brambilla E; Moro D; Gazzeri S; Brambilla C
J Pathol; 1999 Aug; 188(4):351-60. PubMed ID: 10440744
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical detection of the cyclin-dependent kinase inhibitor 2/multiple tumor suppressor gene 1 (CDKN2/MTS1) product p16INK4A in archival human solid tumors: correlation with retinoblastoma protein expression.
Geradts J; Kratzke RA; Niehans GA; Lincoln CE
Cancer Res; 1995 Dec; 55(24):6006-11. PubMed ID: 8521382
[TBL] [Abstract][Full Text] [Related]
9. The cyclin D1 high and cyclin E high subgroups of breast cancer: separate pathways in tumorogenesis based on pattern of genetic aberrations and inactivation of the pRb node.
Lodén M; Stighall M; Nielsen NH; Roos G; Emdin SO; Ostlund H; Landberg G
Oncogene; 2002 Jul; 21(30):4680-90. PubMed ID: 12096344
[TBL] [Abstract][Full Text] [Related]
10. p53, p21, pRB, and p16 expression predict clinical outcome in cystectomy with bladder cancer.
Shariat SF; Tokunaga H; Zhou J; Kim J; Ayala GE; Benedict WF; Lerner SP
J Clin Oncol; 2004 Mar; 22(6):1014-24. PubMed ID: 14981102
[TBL] [Abstract][Full Text] [Related]
11. Concomitant analysis of p16/INK4, cyclin D1, and retinoblastoma protein expression in esophageal squamous cell carcinoma.
Nakamura T; Ide H; Eguchi R; Hayashi K; Takasaki K
Hepatogastroenterology; 2003; 50(53):1321-6. PubMed ID: 14571727
[TBL] [Abstract][Full Text] [Related]
12. Expression of p16 and lack of pRB in primary small cell lung cancer.
Yuan J; Knorr J; Altmannsberger M; Goeckenjan G; Ahr A; Scharl A; Strebhardt K
J Pathol; 1999 Nov; 189(3):358-62. PubMed ID: 10547597
[TBL] [Abstract][Full Text] [Related]
13. Alterations of the cyclin D1/p16-pRB pathway in mantle cell lymphoma.
Dreyling MH; Bullinger L; Ott G; Stilgenbauer S; Müller-Hermelink HK; Bentz M; Hiddemann W; Döhner H
Cancer Res; 1997 Oct; 57(20):4608-14. PubMed ID: 9377576
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of key cell cycle genes (p16/cyclin D1/pRb) in head and neck squamous carcinomas.
Lai S; El-Naggar AK
Lab Invest; 1999 Mar; 79(3):255-60. PubMed ID: 10092061
[TBL] [Abstract][Full Text] [Related]
15. Abnormal expression of Rb pathway-related proteins in salivary gland acinic cell carcinoma.
Liu T; Zhu E; Wang L; Okada T; Yamaguchi A; Okada N
Hum Pathol; 2005 Sep; 36(9):962-70. PubMed ID: 16153458
[TBL] [Abstract][Full Text] [Related]
16. Alterations of Rb pathway (Rb-p16INK4-cyclin D1) in preinvasive bronchial lesions.
Brambilla E; Gazzeri S; Moro D; Lantuejoul S; Veyrenc S; Brambilla C
Clin Cancer Res; 1999 Feb; 5(2):243-50. PubMed ID: 10037171
[TBL] [Abstract][Full Text] [Related]
17. Alterations of the p16/Rb/cyclin-D1 pathway in vulvar carcinoma, vulvar intraepithelial neoplasia, and lichen sclerosus.
Lerma E; Esteller M; Herman JG; Prat J
Hum Pathol; 2002 Nov; 33(11):1120-5. PubMed ID: 12454817
[TBL] [Abstract][Full Text] [Related]
18. Cell cycle regulators in bladder cancer: relationship to schistosomiasis.
Eissa S; Ahmed MI; Said H; Zaghlool A; El-Ahmady O
IUBMB Life; 2004 Sep; 56(9):557-64. PubMed ID: 15590562
[TBL] [Abstract][Full Text] [Related]
19. Abnormal expression of cell cycle regulatory proteins in ductal and lobular carcinomas of the breast.
Geradts J; Ingram CD
Mod Pathol; 2000 Sep; 13(9):945-53. PubMed ID: 11007034
[TBL] [Abstract][Full Text] [Related]
20. Aberrant expression of cell-cycle regulatory proteins in human mesenchymal neoplasia.
Creager AJ; Cohen JA; Geradts J
Cancer Detect Prev; 2001; 25(2):123-31. PubMed ID: 11341347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]